Molecular imaging to guide cancer surgery

12:15-13:00

David Tuch, CEO, Lightpoint Medical

David willl discuss the engineering design principles behind the LightPath™ Imaging System, the world’s first approved medical device for molecular imaging in surgery. Delegates will learn about the challenges and opportunities of product development in advanced medical imaging.